SMASH: Study to Evaluate the Clinical Efficacy of an Extensively Hydrolysed Infant Formula With Synbiotics and a Human Milk Oligosaccharide (HMO) in Infants With Cow's Milk Protein Allergy (CMPA)
N/A
Cow's milk protein allergy (CMPA) is one of the most common food allergies ...
Status
Recruiting
Location
Quironsalud Valencia Hospital
Start Date
2025-02-07
Trial ID
NCT07342621
Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function
NA
The main purpose of this study is to assess the efficacy of a partially hyd...
A Clinical Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on Gut Microbiota Composition and Clinical Effectiveness in Infants at High Risk of Developing Allergy
PHASE3
With the rising prevalence of allergic diseases and the subsequent risk of ...